Streetbeat News

Earnings

OBE

Obsidian Energy reported Q3 earnings of $0.30 per share, missing the analyst consensus estimate of $0.31 by 3.23 percent. This represents a 37.5 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:27 pm

HUBS

HubSpot's shares are trading higher following the company's Q3 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:27 pm

LABP

Landos Biopharma reported Q3 losses of $(0.94) per share, missing the analyst consensus estimate of $(0.88) by 6.82 percent. This is a 53 percent increase over losses of $(2.00) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:27 pm

EWTX

Edgewise Therapeutics reported Q3 losses of $(0.41) per share, missing the analyst consensus estimate of $(0.40) by 2.5 percent. This represents a 20.59 percent increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:26 pm

CMPX

Compass Therapeutics has reported its Q3 2023 earnings per share (EPS) at $(0.08), which is an improvement from $(0.12) year-over-year (YoY).

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:26 pm

APP

AppLovin Corporation's shares are trading higher following the release of its Q3 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:25 pm

BDX

Becton, Dickinson and Company (BDX) reported mixed Q4 financial results and issued FY24 adjusted EPS and revenue guidance below estimates, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:24 pm

SPGC

Sacks Parente Golf (NASDAQ:SPGC) reported Q3 losses of $(0.09) per share, an 80% decrease YoY. However, the company's sales increased by 97.92% to $95.00K from $48.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:23 pm

IMNM

Immunome (NASDAQ:IMNM) reported Q3 losses of $(0.36) per share, a 52% increase from $(0.75) per share YoY. The company also reported $3.56 million in sales this quarter.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:21 pm

AEZS

AEterna Zentaris reported Q3 losses of $(0.85) per share, missing the analyst consensus estimate of $(0.61) by 39.34 percent. This represents a 21.43 percent decrease over losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:20 pm